Leverage Analysis Stories
PNC Financial Services carries a debt of 58.71 billion, with a debt to equity (D/E) ratio of 0.73. This is acceptable considering its current industry classification. The asset utilization indicator represents the revenue generated for every dollar of assets reported by a company.
| over three months ago at Macroaxis By Aina Ster |  |
Cash is king in the realm of investing, and Loop Industries (LOOP) is sitting on a throne with a begin period cash flow of $44.1M. Despite a net income loss of $21.3M, Loop's strong cash position and minimal short long term debt of $3.3M provide the company with the financial flexibility it needs to navigate through any potential economic downturns. Further, with total current liabilities at $3.6M and net invested capital of $37M, the company's debt obligations are easily manageable.
| over three months ago at Macroaxis By Vlad Skutelnik |  |
As we approach February, investors should keep an eye on Neogen Corporation (NASDAQ: NEOG), a key player in the Diagnostics & Research industry within the Healthcare sector. Despite a loss of $22.9M applicable to common shares in the last fiscal year ending in May, the company's robust total revenue of $822.4M and gross profit of $406M indicate a strong financial foundation. However, potential dips in Neogen's performance could offer attractive entry points for investors.
| over three months ago at Macroaxis By Gabriel Shpitalnik |  |
Investing in Helen of Troy (NASDAQ: HELE), a key player in the Household & Personal Products industry, presents a unique opportunity from a leverage viewpoint. The company's significant gross profit of 899.4M is a strong indicator of its financial health, providing a cushion against potential downturns. However, investors should also consider the company's high capital expenditures of 174.9M, which could impact the firm's ability to generate positive cash flow, currently at 33.4M.
| over three months ago at Macroaxis By Vlad Skutelnik | |
There are a few different types of loans that you can apply for, even if you do have a poor credit history. Just remember that you might pay a higher interest, have shorter repayment periods, and other limitations, but it is a good chance to take out a loan to help you with your current needs, and if you maintain consistency with paying back your bad credit loans on time, it will only help you build a good credit score for the future. This will open up a whole new world of possibilities when it comes to available credit and lower interest. If you are struggling with debt and you are worried about your mental health, there are some debt charities out there that can help you.
| over three months ago at Macroaxis By Aina Ster | |
AngioDynamics currently holds $49.82 million in liabilities, with a Debt to Equity (D/E) ratio of 0.14. This suggests that AngioDynamics may not be leveraging borrowing to its full potential. The company's current ratio stands at 2.23, indicating that it is sufficiently liquid and capable of meeting its financial obligations as they come due.
| over three months ago at Macroaxis By Vlad Skutelnik | |
Constellation Brands, a prominent player in the Beverages - Wineries & Distilleries industry, presents an intriguing investment opportunity this February. Despite a Total Risk Alpha of -0.37, indicating a potential loss, the company's robust Free Cash Flow of $1.7B and substantial Retained Earnings of $12.3B suggest a strong financial backbone. Furthermore, with a Mean Deviation of 0.97, the stock's price volatility is relatively low, which could be appealing for investors seeking a stable investment.
| over three months ago at Macroaxis By Vlad Skutelnik | |
Smart Global Holdings carries a debt of 856.85 million, with a debt to equity (D/E) ratio of 1.78. This is acceptable considering its current industry classification. The company's current ratio stands at 2.19, indicating that it is liquid and capable of meeting its financial obligations when they are due.
| over three months ago at Macroaxis By Raphi Shpitalnik |  |
In the world of finance, it's often said that the devil is in the details. This is particularly true when examining the financial outlook of Redhill Biopharma, a key player in the healthcare and pharmaceuticals sector. With a net invested capital of $66.8M and total assets amounting to $158.9M, the company's financial health appears robust at first glance.
| over three months ago at Macroaxis By Vlad Skutelnik | |